Front | Back |
TARGETS OF CNS DRUG ACTION
|
1. Types of Ion Channels
2. Types of Receptor-Channel coupling 3. Role of the Ion current carried by the channel |
TYPES OF ION CHANNELS
|
1. Voltage gated Channels
2. Ligand Gated Channels |
VOLTAGE GATED CHANNELS
|
Voltage-gated ion channels respond
to changes in membrane potential.concentrated on the axons of nerve
cells and include the sodium channels responsible for action potential
propagation.
Cell bodies and dendrites also
have voltage-sensitive ion channels for potassium and calcium.
|
LIGAND GATED CHANNELS
|
Ligand-gated ion channels (also
called ionotropic receptors) respond to chemical neurotransmitters that bind to
receptor subunits present in their macromolecular structure.
Neurotransmitters also bind to G
protein-coupled receptors (metabotropic receptors) that can modulate voltage-gated
ion channels.
Neurotransmitter-coupled ion
channels are found on :
1.
cell bodies and on presynaptic synapses
2.
cell bodies on the postsynaptic side of synapse.
|
TYPES OF RECEPTOR-CHANNEL COUPLING
|
ligand-gated ion
channels: activation(or inactivation) is initiated by the interaction between
chemical neurotransmitters and their
receptors Coupling may be
(1) through a receptor that acts directly on the channel
protein (B)
(2) through a receptor that is coupled to the ion channel
through a G protein (C)
(3) through a
receptor coupled to a G protein that modulates the formation of diffusible
second messengers--including cAMP, inositol trisphosphate (IP3) , and diacyl- glycerol
(DAG)--which secondarily modulate ion channels (D).
|
TYPES OF ION CURRENTS CARRIED BY THE CHANNEL
|
1. EPSPs
2. IPSPs |
EXCITATORY POSTSYNAPTIC POTENTIALS (EPSPs)
|
Excitatory postsynaptic potentials (EPSPs) are usually
generated by the opening of sodium or calcium channels. In some synapses, similar depolarizing potentials result from the
closing of potassium channels.
|
INHIBITORY POSTSYNAPTIC POTENTIALS (IPSPs)
|
Inhibitory postsynaptic potentials (IPSPs) are generated by
the opening of potassium or chloride channels. For example, activation of
postsynaptic metabotropic receptors increases the efflux of potassium.
Presynaptic inhibition can occur via a decrease in calcium influx elicited by
activation of metabotropic receptors.
|
SITES OF DRUG ACTION
|
1. through direct interactions with molecular components of ion channels on axons
ex. carbamazepine phenytoin 2. at synapses |
CNS DIVISIONS
|
1. Hierarchial System
2. Diffuse System |
HIERARCHIAL SYSTEM
|
clearly delimited in their anatomic distribution
generally contain large myelinated, rapidly Conducting
fibers.
control major sensory and motor functions.
excitatory transmitters =
aspartate and glutamate.
numerous small inhibitory interneurons, which
utilize 3,-aminobutyric acid (GABA) or glycine as transmitters.
Drugs that affect hierarchical systems often have profund
effects on the overall excitability
of the CNS.
|
DIFFUSE SYSTEM
|
broadly distributed,
with single cells frequently sending processes to many different areas.
The axons are fine and branch repeatedly to form synapses
with many cells.
Axons commonly have periodic enlargements (varicosities) that
contain transmitter vesicles.
The transmitters = amines (norepinephrine, dopamine, serotonin)
or peptides = exert actions on metabotropic receptors.
Drugs that affect these systems have marked
effects on attention, appetite, and emotional states.
|
TRANSMITTERS AT CENTRAL SYNAPSES
|
1. Acetylcholine
2. Dopamine 3. Norepinephrine 4. Serotonin 5. Glutamic Acid 7. Gaba and Glycine 8. Peptide Transmitters 9. Endocannabinoids |
CRITERIS TO BE A TRANSMITTER
|
chemical must be present in higher concentration in the
synaptic area than in other areas (ie, must be localized in appropriate areas)
must be released by electrical or chemical stimulation via a
calcium-dependent mechanism
must produce the same
sort of postsynaptic response that is seen with physiologic activation of the
synapse (ie, must exhibit synaptic mimicry).
|
ACETYLCHOLINE
|
mediated by a large family of G protein-coupled muscarinic M
receptors that lead to slow excitation when activated = involves a decrease in
membrane permeability to potassium.
nicotinic receptors = those on the Renshaw cells activated
by motor axon collaterals in the spinal cord
Drugs affecting the
activity of cholinergic systems in the brain include the
acetylcholinesterase inhibitors used in Alzheimer's disease
(eg, tacrine)
muscarinic blocking agents used in parkinsonism (eg,
benztropine).
|